Blood pressure-lowering peptides from neo-fermented buckwheat sprouts: A new approach to estimating ACE-inhibitory activity

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Koyama, Masahiro ^a   Hattori, Seiji ^a   Amano, Yoshihiko ^a   Watanabe, Masanori ^b   Nakamura, Kozo ^a  

^a SHINSHU UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTYLVALYLTRYPTOPHYLTYROSINE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PHENYLALANYLASPARTYLALANYLARGINYLTHREONINE; PHENYLALANYLGLUTAMINE; TRYPTOPHYLTHREONYLPHENYLALANYLARGININE; UNCLASSIFIED DRUG; VALYLALANYLGLUTAMIC ACID; VALYLVALINE; ANGIOTENSIN I; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BIOACCUMULATION; BUCKWHEAT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG MECHANISM; ENZYME INHIBITION; EX VIVO STUDY; FERMENTATION TECHNIQUE; HYPERTENSION; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; RAT; SINGLE DRUG DOSE; SPROUT; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; VASODILATATION; ANIMAL; BLOOD PRESSURE; CHEMISTRY; DRUG EFFECTS; FAGOPYRUM; FERMENTATION; IN VITRO STUDY; ISOLATION AND PURIFICATION; METABOLISM; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FAGOPYRUM; FERMENTATION; IN VITRO TECHNIQUES; MALE; PLANT EXTRACTS; RATS, INBRED SHR;

EID: 84907192465     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105802     Document Type: Article

References (26)

1. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, et al. (1988) Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 85: 9386-9390.
2. Heeneman S, Sluimer JC, Daemen MJ (2007) Angiotensin-converting enzyme and vascular remodeling. Circ Res 101: 441-454.
3. Falkenhahn M, Franke F, Bohle RM, Zhu YC, Stauss HM, et al. (1995) Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension 25: 219-226.
4. Fukuhara M, Geary RL, Diz DI, Gallagher PE, Wilson JA, et al. (2000) Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. Hypertension 35: 353-359.
5. Fukuda N, Hu WY, Satoh C, Nakayama M, Kishioka H, et al. (1999) Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 17: 1099-1107.
6. Izzo JL Jr, Weir MR (2011) Angiotensin-converting enzyme inhibitors. J Clin Hypertens 13: 667-675.
7. Nakamura Y, Yamamoto N, Sakai K, Takano T (1995) Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J Dairy Sci 78: 1253-1257.
8. Seki E, Kawasaki T, Yoshida M, Osajima K, Tamaya K, et al. (1999) Antihypertensive effect of sardine peptide and Valyl-Tyrosine in spontaneously hypertensive rats. J Jpn Soc Nutr Food Sci 52: 271-277.
9. Iwai K, Hasegawa T, Taguchi Y, Morimatsu F, Sato K, et al. (2005) Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. J Agric Food Chem 53: 6531-6536.
10. Vermeirssen V, Van CJ, Verstraete W (2004) Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br J Nutr 92: 357-366.
11. Nakamura K, Naramoto K, Koyama M (2013) Blood-pressure-lowering effect of fermented buckwheat sprouts in spontaneously hypertensive rats. J Funct Foods 5: 406-415.
12. Koyama M, Naramoto K, Nakajima T, Aoyama T, Watanabe M, et al. (2013) Purification and identification of anti-hypertensive peptides from fermented buckwheat sprouts. J Agric Food Chem 61: 3013-3021.
13. Axelband F, Assunção-Miranda I, de Paula IR, Ferrão FM, Dias J, et al. (2009) Ang-(3-4) suppresses inhibition of renal plasma membrane calcium pump by Ang II. Regul Pept 155: 81-90.
14. Burgaud JL, Oudart N (1994) NG-nitro-L-arginine methyl ester inhibits the effect of an H3-histaminergic receptor agonist on NANC contraction in guinea-pig perfused bronchioles. J Pharm Pharmacol 46: 153-155.
15. Kouno K, Hirano S, Kuboki H, Kasai M, Hatae K (2005) Effects of dried bonito (Katsuobushi) and captopril, an angiotensin I-converting enzyme inhibitor, on rat isolated aorta: a possible mechanism of antihypertensive action. Biosci Biotechnol Biochem 69: 911-915.
16. Rosendorff C, Black HR (2009) Evidence for a lower target blood pressure for people with heart disease. Curr Opin Cardiol 24: 318-324.
17. Yoshiji H, Fukui H (2004) Vascular endothelial growth factor. J Nara Med Assoc 55: 63-72.
18. Russell JC, Proctor SD (2006) Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. Cardiovasc Pathol 15: 318-330.
19. Fukuda N, Satoh C, Hu WY, Soma M, Kubo A, et al. (1999) Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 19: 1210-1217.
20. Gohlke P, Lamberty V, Kuwer I, Bartenbach S, Schnell A, et al. (1993) Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate. Hypertension 22: 682-687.
21. Hayashi A, Kimoto K (2010) Studies on the mechanism of antihypertensive action by nicotianamine. J Nutr Sci Vitaminol 56: 242-246.
22. Feher A, Cassuto J, Szabo A, Patel V, Vinayak KM, et al. (2013) Increased tissue angiotensin-converting enzyme activity impairs bradykinin-induced dilation of coronary arterioles in obesity. Circ J 77: 1867-1876.
23. Olszanecki R, Bujak-Gizycka B, Madej J, Suski M, Wołkow PP, et al. (2008) Kaempferol, but not resveratrol inhibits angiotensin converting enzyme. J Physiol Pharmacol 59: 387-392.
24. Carey RM (2004) Angiotensin type-1 receptor blockade increases ACE 2 expression in the heart. Hypertension 43: 943-944.
25. Jakala P, Vapaatalo H (2010) Antihypertensive Peptides from Milk Proteins. Pharmaceuticals 3: 251-272.
26. Matsui T, Imamura M, Oka H, Osajima K, Kimoto K, et al. (2004) Tissue distribution of antihypertensive dipeptide, Val-Tyr, after its single oral administration to spontaneously hypertensive rats. J Pept Sci 10: 535-545.